These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools. Issa NT; Wathieu H; Ojo A; Byers SW; Dakshanamurthy S Curr Drug Metab; 2017; 18(6):556-565. PubMed ID: 28302026 [TBL] [Abstract][Full Text] [Related]
68. The future of toxicology--wrap up. Jacobs AT; Marnett LJ Chem Res Toxicol; 2007 Jul; 20(7):983-5. PubMed ID: 17630814 [No Abstract] [Full Text] [Related]
69. Informed toxicity assessment in drug discovery: systems-based toxicology. Mayne JT; Ku WW; Kennedy SP Curr Opin Drug Discov Devel; 2006 Jan; 9(1):75-83. PubMed ID: 16445119 [TBL] [Abstract][Full Text] [Related]
70. In silico prediction of ADMET properties: how far have we come? Dearden JC Expert Opin Drug Metab Toxicol; 2007 Oct; 3(5):635-9. PubMed ID: 17916052 [TBL] [Abstract][Full Text] [Related]
71. [Adverse Effect Predictions Based on Computational Toxicology Techniques and Large-scale Databases]. Uesawa Y Yakugaku Zasshi; 2018; 138(2):185-190. PubMed ID: 29386432 [TBL] [Abstract][Full Text] [Related]
73. Protein biomarkers for in vitro testing of toxicology. Schrattenholz A; Šoškić V; Schöpf R; Poznanović S; Klemm-Manns M; Groebe K Mutat Res; 2012 Aug; 746(2):113-23. PubMed ID: 22405942 [TBL] [Abstract][Full Text] [Related]
74. Prospects and Frontiers of Stem Cell Toxicology. Liu S; Yin N; Faiola F Stem Cells Dev; 2017 Nov; 26(21):1528-1539. PubMed ID: 28874109 [TBL] [Abstract][Full Text] [Related]
75. Developing a Multi-Dose Computational Model for Drug-Induced Hepatotoxicity Prediction Based on Toxicogenomics Data. Su R; Wu H; Xu B; Liu X; Wei L IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(4):1231-1239. PubMed ID: 30040651 [TBL] [Abstract][Full Text] [Related]
76. Tools for evidence-based toxicology: computational-based strategies as a viable modality for decision support in chemical safety evaluation and risk assessment. Valerio L Hum Exp Toxicol; 2008 Oct; 27(10):757-60. PubMed ID: 19042961 [No Abstract] [Full Text] [Related]
77. The evolution of bioinformatics in toxicology: advancing toxicogenomics. Afshari CA; Hamadeh HK; Bushel PR Toxicol Sci; 2011 Mar; 120 Suppl 1(Suppl 1):S225-37. PubMed ID: 21177775 [TBL] [Abstract][Full Text] [Related]
78. Computational chemistry, systems biology and toxicology. Harnessing the chemistry of life: revolutionizing toxicology. a commentary. Kimber I; Humphris C; Westmoreland C; Alepee N; Negro GD; Manou I J Appl Toxicol; 2011 Apr; 31(3):206-9. PubMed ID: 21404310 [TBL] [Abstract][Full Text] [Related]
79. Drug safety Africa: An overview of safety pharmacology & toxicology in South Africa. Guth BD; Grobler AF; Frazier KS; Greiter-Wilke A; Herzyk D; Hough TA; Khan AA; Markert M; Smith JD; Svenson KL; Wells S; Pugsley MK J Pharmacol Toxicol Methods; 2019; 98():106579. PubMed ID: 31085319 [TBL] [Abstract][Full Text] [Related]
80. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling. Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]